Sign In
Get Clay Free →

Suggestions

    Michael Geranen

    Chief Executive Officer

    Michael Geranen is an experienced CEO with a strong background in the pharmaceutical industry, currently serving as the Chief Executive Officer and Co-Founder of Captura BioPharma LLC since February 2019.12 He is a U.S. Army veteran, having served as a Ranger in the 1/75th Ranger Regiment from 1991 to 1995.12

    Geranen's expertise spans various aspects of the pharmaceutical sector, including:

    • Finance and product development in both branded and generic pharmaceuticals
    • Working with the U.S. Food and Drug Administration (FDA)
    • Strategic planning and financial structuring
    • International market operations and strategic alliances
    • Developing novel financing mechanisms and securing government grants12

    Prior to his current role, Geranen held several notable positions:

    • President and CEO of Ezra Innovations LLC (April 2008 - February 2019)
    • Managing Director at CAM-Global LLC (2008 - 2011)
    • Business Development at SinoFresh (2006 - 2008)
    • Managing Director at Madison Keats, a Life Sciences Investment Bank (February 2001 - March 2006)1

    At Captura BioPharma, Geranen is leading the development of C2E2, a decorporation agent for radiation exposure. The company, based in Little Rock, Arkansas, was founded on research from the University of North Carolina and has received funding from the National Institutes of Health and private investors.3

    Geranen's educational background includes studies at Suomi Lutheran College.14 His career demonstrates a strong track record in pharmaceutical development, corporate strategy, and financial management within the life sciences sector.

    Related Questions

    What is the primary focus of Captura BioPharma LLC?
    How did Michael Geranen's experience in the U.S. Army Ranger influence his career in pharmaceuticals?
    What are the key achievements of Michael Geranen at Ezra Innovations LLC?
    How does Captura BioPharma's lead product, C2E2, differ from other radiation exposure treatments?
    What strategic alliances has Michael Geranen established in the international pharmaceutical market?
    Michael Geranen
    Michael Geranen, photo 1
    Michael Geranen, photo 2
    Add to my network

    Location

    Little Rock, Arkansas, United States